… for use as immunosuppressants in solid organ transplantation. This review focuses on those
drugs that have proven immunosuppressive activity in patients ( 1 , 2 ). Tacrolimus (FK 506) …

… Immunosuppressive drugs used in the transplantation period are generally defined as
induction and maintenance therapy. The use of immunosuppressants, which are particularly …

… immunosuppressive therapy. Organ transplantation, in the absence of immunosuppressive
drugs, … in the absence of drug therapy in almost all donor–recipient combinations. The goal of …

… transplant recipients and while no immunosuppressive drug has been directly associated
with cardiovascular events, immunosuppressive drugs … for post-transplant hyperlipidaemia. …

… Post-liver transplant patient … of immunosuppressive drugs. Data from United Network for
Organ Sharing (UNOS) database and liver registry with Organ Procurement and Transplantation …

… drugs can be severe, which is one of the reasons that life expectancy of transplant patients
… In this review manuscript we will discuss current and future immunosuppressive strategies …

… , both in transplant and non-transplant patients. The increasing use of immunosuppressive
drugs in non-transplant patients … immunosuppression with respect to the risk of malignancies. …

… metabolizing enzymes and drug transporters, associations … of immunosuppressive drugs
can be established. Such studies have been done for almost all immunosuppressive drugs. …

… At present, multi-drug therapy is used in the clinic following organ … A more detailed
description of the hrst 20 liver transplant patients re ceiving FK 506. Of these patients, 15 were …

… Gastrointestinal disturbances can lead to a modified exposure to immunosuppressive drugs…
of the immunosuppressive drugs and how to adjust immunosuppressive therapy in patients …